XIANGPING FANG: Open Payments
NPI 1649670399 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 85 payments from 16 companies in 2025. Trend: 2023 $1,535 · 2024 $2,898 · 2025 $1,771
Food & beverage: $1,604Education: $167
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $431 |
| GENZYME CORPORATION | 7 | $195 |
| ABBVIE INC. | 16 | $195 |
| LEO Pharma Inc. | 6 | $179 |
| Regeneron Healthcare Solutions, Inc. | 8 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
| Lilly USA, LLC | 5 | $122 |
| Incyte Corporation | 5 | $89 |
| Galderma Laboratories, L.P. | 3 | $64 |
| Organon LLC | 2 | $38 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ADBRY, COSENTYX, LIBTAYO, TALTZ, OPZELURA.
Industry payments across AZ — which companies pay providers there.
